Camillio Porta (Camillo Porta)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 23

Top Topics

Brain Metastases

Systematic Review

Renal Cell Carcinoma

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Valeria Internò, Maria Chiara Sergi, Maria Elvira Metta, Michele Guida, Paolo Trerotoli, Sabino Strippoli, Salvatore Circelli, Camillio Porta, Marco Tucci
Melanoma Brain Metastases: A Retrospective Analysis of Prognostic Factors and Efficacy of Multimodal Therapies. Cancers 15 (5) (2023)
Valeria Internò, Maria Chiara Sergi, Maria Elvira Metta, Michele Guida, Paolo Trerotoli, Sabino Strippoli, Salvatore Circelli, Camillio Porta, Marco Tucci
Melanoma Brain Metastases: A Retrospective Analysis of Prognostic Factors and Efficacy of Multimodal Therapies. Cancers 15 (5) (2023)
Davide Loizzo, Savio Domenico Pandolfo, Devin Rogers, Clara Cerrato, Nicola Antonio di Meo, Riccardo Autorino, Vincenzo Mirone, Matteo Ferro, Camillio Porta, Alessandro Stella, Cinzia Bizzoca, Leonardo Vincenti, Marco Spilotros, Monica Rutigliano, Michele Battaglia, Pasquale Ditonno, Giuseppe Lucarelli
Novel Insights into Autophagy and Prostate Cancer: A Comprehensive Review. International journal of molecular sciences 23 (7) (2022)
Matteo Brunelli, Guido Martignoni, Giorgio Malpeli, Alessandro Volpe, Luca Cima, Maria Rosaria Raspollini, Mattia Barbareschi, Alessandro Tafuri, Giulia Masi, Luisa Barzon, Serena Ammendola, Manuela Villanova, Maria Angela Cerruto, Michele Milella, Sebastiano Buti, Melissa Bersanelli, Giuseppe Fornarini, Sara Elena Rebuzzi, Valerio Gaetano Vellone, Gabriele Gaggero, Giuseppe Procopio, Elena Verzoni, Sergio Bracarda, Martina Fanelli, Roberto Sabbatini, Rodolfo Passalacqua, Bruno Perrucci, Maria Olga Giganti, Maddalena Donini, Stefano Panni, Marcello Tucci, Veronica Prati, Cinzia Ortega, Anna Caliò, Albino Eccher, Filippo Alongi, Giovanni Pappagallo, Roberto Iacovelli, Alessandra Mosca, Paolo Umari, Ilaria Montagnani, Stefano Gobbo, Francesco Atzori, Enrico Munari, Marco Maruzzo, Umberto Basso, Francesco Pierconti, Carlo Patriarca, Piergiuseppe Colombo, Alberto Lapini, Giario Conti, Roberto Salvioni, Enrico Bollito, Andrea Cossarizza, Francesco Massari, Mimma Rizzo, Renato Franco, Federica Zito-Marino, Yoseba Aberasturi Plata, Francesca Galuppini, Marta Sbaraglia, Angelo Paolo Dei Tos, Angelo Paolo Dei Tos, Maurizio Colecchia, Holger Moch, Maurizio Scaltriti, Camillio Porta, Brett Delahunt, Gianluca Giannarini, Roberto Bortolus, Pasquale Rescigno, Giuseppe Luigi Banna, Alessio Signori, Miguel Angel Llaja Obispo, Roberto Perris, Alessandro Antonelli
Validation of a Novel Three-Dimensional ( 3D Fusion ) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study. Journal of personalized medicine 12 (5) (2022)
Ben Sprangers, David E Leaf, Camillio Porta, Maria José Soler, Mark A Perazella
Diagnosis and management of immune checkpoint inhibitor-associated acute kidney injury. Nature reviews. Nephrology 18 (12) (2022)
Nicola Antonio di Meo, Davide Loizzo, Savio Domenico Pandolfo, Riccardo Autorino, Matteo Ferro, Camillio Porta, Alessandro Stella, Cinzia Bizzoca, Leonardo Vincenti, Felice Crocetto, Octavian Sabin Tătaru, Monica Rutigliano, Michele Battaglia, Pasquale Ditonno, Giuseppe Lucarelli
Metabolomic Approaches for Detection and Identification of Biomarkers and Altered Pathways in Bladder Cancer. International journal of molecular sciences 23 (8) (2022)
Caterina Caminiti, Jane Bryce, Silvia Riva, Diane Ng, Francesca Diodati, Elisa Iezzi, Lucia Sparavigna, Silvia Novello, Camillio Porta, Lucia Del Mastro, Giuseppe Procopio, Saverio Cinieri, Amalia Falzetta, Fabio Calabrò, Vito Lorusso, Alessio Aligi Cogoni, Giampaolo Tortora, Marco Maruzzo, Rodolfo Passalacqua, Francesco Cognetti, Vincenzo Adamo, Enrica Capelletto, Alessandra Ferrari, Michela Bagnalasta, Maurizio Bassi, Annalisa Nicelli, Davide De Persis, Alessia D'Acunti, Elisabetta Iannelli Patient, Francesco Perrone, Sandra A Mitchell
Cultural adaptation of the Italian version of the Patient-Reported Outcomes Common Terminology Criteria for Adverse Event (PRO-CTCAE®). Tumori (2022)
Stephane Marie Oudard, Nadine Benhamouda, Bernard Escudier, Patrice Ravel, Thi Tran, Emeline Levionnois, Sylvie Negrier, Philippe Barthelemy, Jean François Berdah, Marine Gross-Goupil, Cora N Sternberg, Petri Bono, Camillio Porta, Ugo De Giorgi, Omi Parikh, Robert Hawkins, Martin Highley, Jochen Wilke, Thomas Decker, Corinne Tanchot, Alain Gey, Magali Terme, Eric Tartour
Decrease of Pro-Angiogenic Monocytes Predicts Clinical Response to Anti-Angiogenic Treatment in Patients with Metastatic Renal Cell Carcinoma. Cells 11 (1) (2021)
Chiara Guarini, Teresa Grassi, Gaetano Pezzicoli, Camillio Porta
Beyond RAS and BRAF: HER2, a New Actionable Oncotarget in Advanced Colorectal Cancer. International journal of molecular sciences 22 (13) (2021)
Mimma Rizzo, Patrizia Giannatempo, Camillio Porta
Biological Therapeutic Advances for the Treatment of Advanced Urothelial Cancers. Biologics : targets & therapy 15 (2021)
Paola Cafforio, Raffaele Palmirotta, Domenica Lovero, Ettore Cicinelli, Gennaro Cormio, Erica Silvestris, Camillio Porta, Stella D'Oronzo
Liquid Biopsy in Cervical Cancer: Hopes and Pitfalls. Cancers 13 (16) (2021)
Riccardo Marconcini, Gaetano Pezzicoli, Luigia Stefania Stucci, Maria Chiara Sergi, Lucia Lospalluti, Camillio Porta, Marco Tucci
Combination of immunotherapy and other targeted therapies in advanced cutaneous melanoma. Human vaccines & immunotherapeutics (2021)
Gaetano Pezzicoli, Elisabetta Filoni, Angela Gernone, Laura Cosmai, Mimma Rizzo, Camillio Porta
Playing the Devil's Advocate: Should We Give a Second Chance to mTOR Inhibition in Renal Clear Cell Carcinoma? - ie Strategies to Revert Resistance to mTOR Inhibitors. Cancer management and research 13 (2021)
Carmelo Laface, Mariarita Laforgia, Pasquale Molinari, Ippazio Ugenti, Cosmo Damiano Gadaleta, Camillio Porta, Girolamo Ranieri
Hepatic Arterial Infusion of Chemotherapy for Advanced Hepatobiliary Cancers: State of the Art. Cancers 13 (12) (2021)
Antonio Russo, Daniele Fanale, Giuseppe Badalamenti, Camillio Porta, Daniel Olive, Ida De Luca, Chiara Brando, Mimma Rizzo, Carlo Messina, Mattia Rediti, Antonio Russo, Viviana Bazan, Juan Lucio Iovanna
Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 predict response to nivolumab treatment in patients with metastatic renal cell carcinoma: a step toward a biomarker for therapeutic decisions. Oncoimmunology 9 (1) (2020)
Stefania Mantovani, Stefania Varchetta, Dalila Mele, Matteo Donadon, Guido Torzilli, Cristiana Soldani, Barbara Franceschini, Camillio Porta, Silvia Chiellino, Paolo Pedrazzoli, Roberto Santambrogio, Barabino Matteo, Claudia Cigala, Gaetano Piccolo, Enrico Opocher, Marcello Maestri, Angelo Sangiovanni, Stefano Bernuzzi, Florence Lhospice, Manel Kraiem, Mario Umberto Mondelli, Barbara Oliviero
An Anti-MICA/B Antibody and IL-15 Rescue Altered NKG2D-Dependent NK Cell Responses in Hepatocellular Carcinoma. Cancers 12 (12) (2020)
Christopher Montemagno, Anais Hagege, Delphine Borchiellini, Brice Thamphya, Olivia Rastoin, Damien Ambrosetti, Juan Lucio Iovanna, Nathalie Rioux-Leclercq, Camillio Porta, Sylvie Negrier, Jean-Marc Ferrero, Emmanuel Chamorey, Gilles Pagès, Maeva Dufies
Soluble forms of PD-L1 and PD-1 as prognostic and predictive markers of sunitinib efficacy in patients with metastatic clear cell renal cell carcinoma. Oncoimmunology 9 (1) (2020)
Francesco Massari, Veronica Mollica, Alessandro Rizzo, Laura Cosmai, Mimma Rizzo, Camillio Porta
Safety evaluation of immune-based combinations in patients with advanced renal cell carcinoma: a systematic review and meta-analysis. Expert opinion on drug safety 19 (10) (2020)
Camillio Porta, Elena Verzoni, Silvia Zai, Caterina Messina, Vittorio Ferrari, Nicole Gri, Giuseppe Procopio
Use of a natural multicomponent mouthwash plus oral hygiene vs oral hygiene alone to prevent everolimus-induced stomatitis: the STOP multicenter, randomized trial. Tumori (2020)
Stefanie Aeppli, Eric Innocents Eboulet, Tim Eisen, Bernard Escudier, Stefanie Fischer, James Larkin, Viktor Gruenwald, David McDermott, Jan Oldenburg, Aurelius Omlin, Camillio Porta, Brian Rini, Manuela Schmidinger, Cora Sternberg, Christian Rothermundt
Impact of COVID-19 pandemic on treatment patterns in metastatic clear cell renal cell carcinoma. ESMO open 5 (Suppl 3) (2020)
Gaetano Pezzicoli, Marco Tucci, Domenica Lovero, Franco Silvestris, Camillio Porta, Francesco Mannavola
Large Extracellular Vesicles-A New Frontier of Liquid Biopsy in Oncology. International journal of molecular sciences 21 (18) (2020)
Camillio Porta, Patrizia Giannatempo, Mimma Rizzo, Giuseppe Lucarelli, Pasquale Ditonno, Michele Battaglia
An evaluation of UGN-101, a sustained-release hydrogel polymer-based formulation containing mitomycin-C, for the treatment of upper urothelial carcinomas. Expert opinion on pharmacotherapy 21 (18) (2020)
Matteo Santoni, Daniel Y Heng, Sergio Bracarda, Giuseppe Procopio, Michele Milella, Camillio Porta, Marc R Matrana, Giacomo Cartenì, Simon J Crabb, Ugo De Giorgi, Umberto Basso, Cristina Masini, Fabio Calabrò, Maria Giuseppa Vitale, Daniele Santini, Francesco Massari, Luca Galli, Giuseppe Fornarini, Riccardo Ricotta, Sebastiano Buti, Paolo Andrea Zucali, Orazio Caffo, Franco Morelli, Francesco Carrozza, Angelo Martignetti, Alain Gelibter, Roberto Iacovelli, Alessandra Mosca, Francesco Atzori, Nuno Vau, Lorena Incorvaia, Cinzia Ortega, Marina Scarpelli, Antonio López-Beltran, Liang Cheng, Vittorio Paolucci, Jeffrey Graham, Erin Pierce, Sarah Scagliarini, Pierangela Sepe, Elena Verzoni, Sara Merler, Mimma Rizzo, Giulia Sorgentoni, Alessandro Conti, Francesco Piva, Alessia Cimadamore, Rodolfo Montironi, Nicola Battelli
Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors. Cancers 12 (1) (2019)